8-K ·Filed May 4, 2026

VTRS

Viatris Inc
NEUTRAL
Impact 3/10
Horizondays Processed5mo ago SEC0001140361-26-018887
8-K context-dependent: Items 5.02, 7.01
Actionable Insight • Neutral

Monitor Q1 2026 earnings release on May 7 for any guidance changes or unexpected financial results. The CFO transition is orderly, reducing near-term disruption risk.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
VTRS ▲ +14.43% at T+60d
NEUTRAL call ✓ call won +14.43% · α vs SPY +11.69% · entry $15.52 → $17.76
Entry anchored
May 4, 2026
via day open
T+1d
+2.77%
call +2.77% · α +1.39%
$15.95
settled 5mo ago
T+5d
+10.63%
call +10.63% · α +8.65%
$17.17
settled 5mo ago
T+20d
+1.10%
call +1.10% · α -3.86%
$15.69
settled 4mo ago
T+60d
+14.43%
call +14.43% · α +11.69%
$17.76
settled 2mo ago

Price Chart

Loading chart...

Executive Summary

Viatris CFO Theodora Mistras voluntarily departs for another opportunity; CAO Paul Campbell appointed interim CFO effective May 8, 2026. The transition is orderly with no accounting disagreements, and the company will report Q1 2026 results on May 7.

Key Facts

  • CFO Theodora Mistras voluntarily resigns effective May 8, 2026, stays through May 22 for transition.
  • Paul Campbell, Chief Accounting Officer, named interim CFO.
  • Departure not related to accounting or financial statement disagreements.
  • Mistras not eligible for severance or equity vesting; eligible for pro-rata 2026 bonus (at target).
  • Q1 2026 earnings scheduled for release on May 7, 2026.

Financial Impact

No immediate financial impact from the CFO transition; Q1 earnings pending.

none

Risk Factors

  • Potential disruption during CFO search if permanent replacement is delayed.
  • Q1 earnings miss could compound uncertainty from leadership transition.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
67% bullish (18 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001140361-26-018887
Document: ef20072373_ex99-1.htm0001140361-26-018887
Document: 0001140361-26-018887-index-headers.html0001140361-26-018887
Document: 0001140361-26-018887-index.html0001140361-26-018887
Document: 0001140361-26-018887.txt0001140361-26-018887
12 reports for VTRS
Performance horizon
60% Hit rate 3 of 5 directional calls best @ T+60▲ +17.24%May 4, 2026
Filters
Rows
Reports for VTRS — sortable, filterable
TypeNow
Aug 6, 2026
8w ago
8-K
BULLISH ★ 7/10
$16.29 $16.94▲ +3.99%▲ +3.39%$17.60 (+8.04%)
Jun 25, 2026
14w ago
144
NEUTRAL ★ 3/10
$16.33 $17.28▲ +5.82%▲ +4.56%$17.60 (+7.78%)
Jun 18, 2026
15w ago
8-K
NEUTRAL ★ 3/10
$15.38 $17.29▲ +12.42%▲ +12.57%$17.60 (+14.43%)
Jun 15, 2026
15w ago
8-K
NEUTRAL ★ 3/10
$16.04 $16.31▲ +1.68%▲ +1.48%$17.60 (+9.73%)
May 13, 2026
20w ago
Court Ruling
BULLISH ★ 7/10
$17.37 $16.31▼ −6.10%▼ −5.49%$17.60 (+1.32%)
May 7, 2026
21w ago
8-K
BULLISH ★ 7/10
$17.39 $15.56▼ −10.52%▼ −13.66%$17.60 (+1.21%)
May 4, 2026
21w ago
8-K
NEUTRAL ★ 3/10
$15.52 $15.69▲ +1.10%▼ −3.86%$17.60 (+13.40%)
May 4, 2026
21w ago
Court Ruling
NEUTRAL ★ 2/10
$15.20 $15.69▲ +3.22%▼ −2.56%$17.60 (+15.79%)
May 4, 2026
21w ago
Court Ruling
BULLISH ★ 4/10
$15.20 $15.69▲ +3.22%▼ −2.56%$17.60 (+15.79%)
Apr 13, 2026
24w ago
Court Ruling
MIXED ★ 6/10
$13.83 $16.92▲ +22.34%▲ +14.59%$17.60 (+27.26%)
Showing 10 of 12

US Market Status

Market Closed — Opens Mon (65h)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access